1. Home
  2. GKOS vs IBCP Comparison

GKOS vs IBCP Comparison

Compare GKOS & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$115.81

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Independent Bank Corporation

IBCP

Independent Bank Corporation

HOLD

Current Price

$33.31

Market Cap

675.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
IBCP
Founded
1998
1864
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
675.6M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
IBCP
Price
$115.81
$33.31
Analyst Decision
Strong Buy
Hold
Analyst Count
13
3
Target Price
$126.38
$36.00
AVG Volume (30 Days)
694.2K
137.8K
Earning Date
10-29-2025
01-22-2026
Dividend Yield
N/A
3.14%
EPS Growth
N/A
10.56
EPS
N/A
3.25
Revenue
$469,820,000.00
$222,890,000.00
Revenue This Year
$31.15
N/A
Revenue Next Year
$24.15
$5.16
P/E Ratio
N/A
$10.19
Revenue Growth
30.38
7.05
52 Week Low
$73.16
$26.75
52 Week High
$163.71
$37.13

Technical Indicators

Market Signals
Indicator
GKOS
IBCP
Relative Strength Index (RSI) 71.98 47.89
Support Level $115.07 $34.80
Resistance Level $117.94 $35.67
Average True Range (ATR) 2.91 0.75
MACD -0.13 -0.24
Stochastic Oscillator 81.29 6.46

Price Performance

Historical Comparison
GKOS
IBCP

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About IBCP Independent Bank Corporation

Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.

Share on Social Networks: